期刊文献+

肝癌的外科手术治疗 被引量:5

下载PDF
导出
摘要 肝癌起病隐匿,生长迅速,是难治的恶性肿瘤之一。目前肝切除术是主要的治愈性手段,肝切除术的术式大致可分为两大类:规则性肝切除和不规则性肝切除。还有离体和半离体肝切除、腹腔镜肝切除以及目前临床开展的全肝切除肝移植术等新型术式。肝切除术的基本操作技术:肝切除术中控制出血的方法;断肝方法;肝脏断面和胆管的处理方法。
出处 《中国现代医生》 2011年第6期16-18,共3页 China Modern Doctor
关键词 肝癌 肝切除
  • 相关文献

参考文献15

  • 1Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin,2005,55(2):74-108.
  • 2吴孟超.肝癌外科治疗的近期进展[J].中国普外基础与临床杂志,2006,13(2):125-128. 被引量:71
  • 3Hanazaki K,Kajikawa S,Shimozawa N,et al. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma[J]. Hepatogastroenterology,2005,52(62):524-529.
  • 4彭淑牖,李海军.肝切除术中出血的控制[J].肝胆外科杂志,2004,12(3):161-163. 被引量:24
  • 5Makuuchi M,Mori T,Gunven P,et al. Safety of hemihepatic vascular occlusion during resection of the liver[J]. Surg Gynecol Obstet, 1987,164(2) : 155-158.
  • 6Horgan PG,Leen E. A simple technique for vascular control during hepatectomy: the half-Pringle[J]. Am J Surg, 2001,182(3 ) : 265-267.
  • 7Sarely Israela.shvili M,Zippel DB,Kollcr M,et al. Use of transportal balloon catheter occlusion of the portal triad in prevention of bleeding during liver resection[J]. J Surg 0ncol,2005,89(1) :39-42.
  • 8Lesurtel M,Selzner M,Petrewsky H,et al. How should transection of the liver be performed: a prospactive randomized study in 100 consecutive patients: comparing four different transition strategies[J]. Ann Surg,2005,242(6) : 814.
  • 9Heaney JP,Stanton WK,Halbert DS,et al. An improved technic for vascular isolation of the liver: experimental study and case reports[J]. Ann Surg, 1966, 163(2):237-241.
  • 10Fortner JG,Shiu MH,Kinne DW,et al. Major hepatic resection using vascular isolation and hypothermic perfusion[J]. Ann Surg, 1974,180 (4):644-652.

二级参考文献13

  • 1彭淑牖,蔡秀军,李君达,范明敏,束美宝,陈通.不同肝脏功能状况下人肝热缺血时限研究[J].临床外科杂志,1993,1(1):20-21. 被引量:37
  • 2彭淑牖 江献川 冯懿正.选择性入肝血流阻断法在肝切除中的应用[J].实用外科杂志,1989,9(5):264-265.
  • 3El-Scrag HB. Hepatocellular carcinoma: an epidemiologic view[J]. J Clin Gastroenterol, 2002,35(5 Suppl 2): S72
  • 4Lok AS, McMahon BJ; Practice Cuidelines Committee, et al.Chronic hepatitis B: update of recommendations [J]. Hepatology, 2004,39(3):857
  • 5Perrillo R, Hann HW, Mutimer D, et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus [J]. Gastroenterology, 2004,126(1):81.
  • 6Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma [J]. J Am Coll Surg, 2000,191(4):381
  • 7Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters[J]. Ann Surg, 2002,235 (4): 533
  • 8Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time [J]. J Clin Oncol, 2003,21(23):4329
  • 9Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials [J]. Lancet Oncol, 2002,3(10):593.
  • 10耿小平,张宗耀.全肝血流阻断技术在肝外科的地位[J].肝胆外科杂志,1998,6(5):262-263. 被引量:6

共引文献242

同被引文献84

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部